Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEC II Block for Breast Augmentation
NCT03488888Unknown
- Sponsor
- Federal University of São Paulo
- Start
- Nov 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Pain Score at 24 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03488888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03488888.